QuantaLife, based in Pleasanton, has developed a system for digital PCR, or polymerase chain reaction, that can help detect rare mutations.
Wednesday, October 5, 2011
Bio-Rad buys digital PCR developer QuantaLife for $162M
QuantaLife, based in Pleasanton, has developed a system for digital PCR, or polymerase chain reaction, that can help detect rare mutations.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment